VitaNova Life Sciences Corporation Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
VitaNova Life Sciences Corporation (VNOV) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $944 for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-09-14
- VitaNova Life Sciences Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-07-31 was $944.00, a 132.51% increase year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-04-30 was -$2.99K.
- VitaNova Life Sciences Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-07-31 was $406.00.
- VitaNova Life Sciences Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-04-30 was -$10.97K.
- VitaNova Life Sciences Corporation increase (decrease) in other accounts payable and accrued liabilities for fiscal 2026 was $18.07K.
- VitaNova Life Sciences Corporation increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was -$7.48K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-07-31 | $944.00 10-Q · filed 2026-09-14 | -$2.05K derived: sum of 2 quarters · filed 2026-09-14 | ||
| 2026-04-30 | -$2.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $18.07K 10-K · filed 2026-07-29 | ||
| 2026-01-31 | $21.07K 10-Q · filed 2026-03-16 | |||
| 2025-07-31 | $406.00 10-Q · filed 2026-09-14 | -$10.56K derived: sum of 2 quarters · filed 2026-09-14 | ||
| 2025-04-30 | -$10.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$7.48K 10-K · filed 2026-07-29 | ||
| 2025-01-31 | $3.49K 10-Q · filed 2026-03-16 |